drugset / Trial / NCT02458183
Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS
RandomizedParallel-groupOpen-labelPrevention
Summary
The objective of this study is to assess the immunogenicity and safety of the DTaP-IPV combination vaccine compared with those of separate DTaP and IPV vaccines administered to healthy infants at 2, 4, and 6 months of age.
Timeline
- Start
- 2015-02-02
- Primary completion
- 2017-12-19
- Completion
- 2018-05-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | DTaP vaccine | Vaccine | 0.5 ml | Intramuscular |
| Subject | DTaP-IPV combination vaccine | Vaccine | 0.5 ml | Intramuscular |
| Comparator | IPV vaccine | Vaccine | 0.5 ml | Intramuscular |